Is Neurogene Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: NGNE) stock is to Strong Buy NGNE stock.
Out of 2 analysts, 1 (50%) are recommending NGNE as a Strong Buy, 1 (50%) are recommending NGNE as a Buy, 0 (0%) are recommending NGNE as a Hold, 0 (0%) are recommending NGNE as a Sell, and 0 (0%) are recommending NGNE as a Strong Sell.
What is NGNE's revenue growth forecast for 2028-2028?
(NASDAQ: NGNE) Neurogene's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.3%.
Neurogene's revenue in 2024 is $0.
In 2028, NGNE is forecast to generate $368,919,228 in revenue, with the lowest revenue forecast at $368,919,228 and the highest revenue forecast at $368,919,228.
What is NGNE's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: NGNE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
What is NGNE's Price Target?
According to 2 Wall Street analysts that have issued a 1 year NGNE price target, the average NGNE price target is $43.00, with the highest NGNE stock price forecast at $55.00 and the lowest NGNE stock price forecast at $31.00.
On average, Wall Street analysts predict that Neurogene's share price could reach $43.00 by Mar 19, 2025. The average Neurogene stock price prediction forecasts a potential upside of 22.16% from the current NGNE share price of $35.20.
What is NGNE's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: NGNE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.